Answers are grounded in this paper and cite their sources.
Experimental model shows CD38's role in Treg cell resilience against CNS inflammation, implying potential therapeutic strategies.
Foxp3-expressing regulatory T (T reg ) cells protect against systemic autoimmunity. However, little is known about the significance of T reg cells in inflammation-experienced tissues. Here, we use an experimental autoimmune encephalomyelitis model and show that T reg cells accumulate and persist in the central nervous system (CNS) long after the resolution of the bulk of the inflammatory infiltrate. CNS-specific depletion of postinflammatory T reg cells, but not systemic depletion of T reg cells, results in autoimmune inflammatory flares in the CNS by residual local effector T cells. Expression of the NAD-consuming ectoenzyme CD38 is crucial for the functional adaptation of postinflammatory CNS T reg cells to a stressful microenvironment, in which access to interleukin-2 (IL-2) is limited. CD38 counteracts ADP-ribosylation of the IL-2 receptor and thus maintains its high sensitivity to IL-2. This fully functional high-affinity IL-2 receptor prevents the loss of tissue-resident antigen-specific T reg cells. These ‘stress-tolerant’ CNS T reg cells impede the collapse of immune homeostasis in the CNS once acute inflammation is controlled.
No takes yet. Share an insight, caveat, or question.
Chen et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: